Regione autonoma Friuli Venezia Giulia. Linee Guida Regionali per la Gestione delle Polmoniti Batteriche. Online: https://arcs.sanita.fvg.it/media/uploads/2020/05/15/09122014_LG_polmoniti_batt_ott_14_.pdf (Accessed June 2021)

Ten threats to global health in 2019. https://www.who.int/emergencies/ten-threats-toglobal-health-in-2019

Talbot GH, Das A, Cush S, et al; Foundation for the National Institutes of Health Biomarkers Consortium HABP/VABP Project Team. Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. J Infect Dis. 2019;219(10):1536-1544. https://doi.org/10.1093/infdis/jiy578 PMID:30649434 DOI: https://doi.org/10.1093/infdis/jiy578

Inchai J, Pothirat C, Liwsrisakun C, Deesomchok A, Kositsakulchai W, Chalermpanchai N. Ventilator-associated pneumonia: epidemiology and prognostic indicators of 30-day mortality. Jpn J Infect Dis. 2015;68(3):181-186. https://doi.org/10.7883/yoken.JJID.2014.282 PMID:25672347 DOI: https://doi.org/10.7883/yoken.JJID.2014.282

Davis J, Finley E. The breadth of Hospital-Acquired Pneumonia: Nonventilated versus Ventilated Patients in Pennsylvania. Pa Patient Saf Advis. 2012;9(3):99-105.

Sun D, Moorthy V, Chang S-C, et al. Economic Burden of Ventilator-Associated, Hospital-Acquired, Healthcare-Associated and Community-Acquired Pneumonia in the Hospital Setting. Open Forum Infect Dis. 2016;3(suppl 1):1494. Accessed June, 2021. https://doi.org/10.1093/ofid/ofw172.1196 DOI: https://doi.org/10.1093/ofid/ofw172.1196

De Angelis G et al. Burden of Antibiotic Resistant Gram Negative Bacterial Infections: evidence and Limits. J Med Microbiol Diagn. 2014;3:1-6.

Cubist Pharmaceuticals LLC. A prospective, randomized, double-blind, multicenter, Phase 3 study to assess the safety and efficacy of intravenous ceftolozano/tazobactam compared with meropenem in adult patients with Ventilated Nosocomial Pneumonia. (Clinical Study Report: P008MK7625A) 17 October 2018.

Fattore G. Proposta di Linee-Guida per la valutazione economica degli interventi sanitari. PharmacoEcon Ital Res Artic. 2009;11(2):83-93. https://doi.org/10.1007/BF03320660 DOI: https://doi.org/10.1007/BF03320660

Merck & Co. Inc. Program to Assess Ceftolozano/Tazobactam Susceptibility (PACTS) database. 2019.

Raman G, Avendano E, Berger S, Menon V. Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis. BMC Infect Dis. 2015;15(1):395. https://doi.org/10.1186/s12879-015-1123-5 PMID:26423743 DOI: https://doi.org/10.1186/s12879-015-1123-5

Siempos II, Vardakas KZ, Kyriakopoulos CE, Ntaidou TK, Falagas ME. Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis. Shock. 2010;33(6):590-601. https://doi.org/10.1097/SHK.0b013e3181cc0418PMID:19953007 DOI: https://doi.org/10.1097/SHK.0b013e3181cc0418

ISTAT. 2017; Online: http://dati.istat.it/Index.aspx?DataSetCode=DCIS_MORTALITA1#. (Accessed June 2021)

Merck & Co. Inc. IMI/REL model specification validation interviews. June - October 2017.

Whittington MD, Atherly AJ, Curtis DJ, Lindrooth RC, Bradley CJ, Campbell JD. Recommendations for Methicillin-Resistant Staphylococcus aureus Prevention in Adult ICUs: A Cost-Effectiveness Analysis. Crit Care Med. 2017;45(8):1304-1310. https://doi.org/10.1097/CCM.0000000000002484 PMID:28471887 DOI: https://doi.org/10.1097/CCM.0000000000002484

Lee BY, Wiringa AE, Bailey RR, et al. The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2010;31(11):1130-1138. https://doi.org/10.1086/656591 PMID:20923285 DOI: https://doi.org/10.1086/656591

Scalone L, Cortesi P, Ciampichini R et al. Health related quality of life norm data of the general population in Italy: results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiol Biostat Public Health. 2015; 12(3): e11457. http://dx.doi.org/10.2427/11457

ISTAT. Indice dei prezzi al consumo per famiglie, operai ed impiegati. Online: http://rivaluta.istat.it:8080/Rivaluta/(Accessed June 2021)

Joshi M, Metzler M, McCarthy M, Olvey S, Kassira W, Cooper A. Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia. Respir Med. 2006;100(9):1554-1565. https://doi.org/10.1016/j.rmed.2006.01.004 PMID:16487695 DOI: https://doi.org/10.1016/j.rmed.2006.01.004

Lucioni et al., Farmeconomia e percorsi terapeutici. 2001. 2(3). DOI: https://doi.org/10.7175/fe.v2i3.727

Ministero dell’Economia e delle Finanze. Libro verde sulla spesa pubblica. Online: https://www.mef.gov.it/ministero/commissioni/ctfp/documenti/Libro_verde_spesa_pubblica.pdf (Accessed June 2021)

Tariffario nazionale. Remunerazione delle prestazioni di assistenza ospedaliera per acuti, assistenza ospedaliera di riabilitazione e di lungodegenza post acuzie e di assistenza specialistica ambulatoriale. 2013 Online: .https://www.gazzettaufficiale.it/do/atto/serie_generale/caricaPdf?cdimg=13A0052800100010110001&dgu=2013-01-28&art.dataPubblicazioneGazzetta=2013-01-28&art.codiceRedazionale=13A00528&art.num=1&art.tiposerie=SG (Accessed June 2021)

Tariffario delle prestazioni di assistenza specialistica ed ambulatoriale. Online : http://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=28/01/2013&redaz=13A00528&artp=3&art=1&subart=1&subart1=10&vers=1&prog=001(Accessed June 2021)

ISTAT. Tasso di occupazione 2019. Online: http://dati.istat.it/Index.aspx?DataSetCode=DCCV_TAXOCCU1 (Accessed June 2021)

OECD. Average annual wages. Online: https://stats.oecd.org/Index.aspx?DataSetCode=AV_AN_WAGE. (Accessed June 2021)

Kalil AC, Metersky ML, Klompas M, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-e111. https://doi.org/10.1093/cid/ciw353 PMID:27418577 DOI: https://doi.org/10.1093/cid/ciw353

Naik J, Puzniak L, Critchlow S, Elsea D, Dillon RJ, Yang J. Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. Infect Dis Ther. 2021;10(2):939-954. https://doi.org/10.1007/s40121-021-00436-4PMID:33837518 DOI: https://doi.org/10.1007/s40121-021-00436-4

O’Neill J. Wellcome Trust and UK Government. Tackling Drug-Resistant Infections Globally: final report and recommendations. Maggio; 2016.